Skip to main content
logo
Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
235.00
+7.00 (3.07%)
At close: Sep 24, 2026

Taho Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
Market Capitalization
12,3165,7302,274120120616
Market Cap Growth
23.21%151.98%1789.98%0%-80.46%12.10%
Enterprise Value
12,0255,3432,0743939430
Last Close Price
235.00111.5044.352.302.3011.76

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
PS Ratio
6217.00681.34-112.8718.9249.65
PB Ratio
35.7113.524.410.581.313.55
P/TBV Ratio
35.7813.554.410.581.313.94

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
EV/Sales Ratio
-635.26-36.816.1734.70

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
Debt / Equity Ratio
0.030.030.030.11-0.01
Net Debt / Equity Ratio
-0.84-0.89-0.93-1.01-1.15-0.74
Net Debt / EBITDA Ratio
1.221.752.851.761.841.40
Net Debt / FCF Ratio
1.421.812.891.941.670.92
Asset Turnover
0.010.02-0.01-0.05
Inventory Turnover
-----2.18
Quick Ratio
18.1915.0115.023.852.295.13
Current Ratio
18.3015.1215.093.912.395.70
Return on Equity (ROE)
-60.29%-45.62%-46.32%-80.79%--56.44%
Return on Assets (ROA)
-36.52%-27.08%-25.20%-35.89%--25.53%
Return on Capital Employed (ROCE)
-69.70%-51.20%-32.20%-54.20%-72.50%-61.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
Earnings Yield
-1.94%-3.74%-7.36%-100.30%-55.10%-22.27%
FCF Yield
-1.66%-3.65%-7.29%-89.02%-52.87%-22.48%
Buyback Yield / Dilution
-5.52%-13.40%-17.18%-7.73%31.26%-